Home > Insider Trading > Filing (0001437749-17-019919)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1434647	Kempharm Inc	KMPH	Pharmaceutical Preparations (2834)	205894398

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1672300	L Daniel Cohen	C/O Kempharm, Inc. 2500 Crosspark Road, Suite E126 Coralville IA 52241	Evp, Govt. & Public Relations	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2017-11-27	1,145	$3.70	26,145	No	4	P	Direct
Common Stock	Acquisiton	2017-11-27	1,310	$3.75	27,455	No	4	P	Direct
Common Stock	Acquisiton	2017-11-27	2,990	$3.80	30,445	No	4	P	Direct
Common Stock	Acquisiton	2017-11-27	2,055	$3.85	32,500	No	4	P	Direct
Common Stock	Disposition	2017-11-29	2,500	$0.00	30,000	No	4	G	Direct
Common Stock	Acquisiton	2017-11-29	1,250	$0.00	1,250	No	4	G	Indirect	By Daughter.
Common Stock	Acquisiton	2017-11-29	1,250	$0.00	1,250	No	4	G	Indirect	By Daughter.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	G	Direct
No	4	G	Indirect	By Daughter.
No	4	G	Indirect	By Daughter.

Footnotes

The shares are held in an investment account for the benefit of the Reporting Person's daughter. The Reporting Person may be deemed to have indirect beneficial interest in such shares based on his investment control over the daughter's account.
The shares are held in an investment account for the benefit of the Reporting Person's daughter. The Reporting Person may be deemed to have indirect beneficial interest in such shares based on his investment control over the daughter's account.